October Is Breast Cancer Awareness Month

Mount Sinai Experts Offer Tips on Early Detection, Screening, Understanding Risk and Personalized Treatment Options
20-Sep-2017 9:00 AM EDT Add to Favorites

New Initiative Creates Scalable Solutions to Improve Care of Patients with Multiple Chronic Conditions

Teva and Mount Sinai Health System pursue new models to reduce cost and complexity of care
18-Sep-2017 1:05 PM EDT Add to Favorites

Mount Sinai and City Health Works Partner on New Pilot Program: Medicaid Patients with Congestive Heart Failure Coached at Home on Self-Care

City Health Works and Mount Sinai St. Luke’s (MSSL) are collaborating on a one-year pilot, launched in mid-July, to reduce hospital readmissions for patients with congestive heart failure.
13-Sep-2017 12:05 PM EDT Add to Favorites

Scientists Reveal New Insights and Possible Solutions for Opioid Epidemics Using Machine Learning

Mount Sinai researchers have identified unique structural, biological and chemical insights in the way different opioid drugs activate the receptors and specific signaling pathways responsible for the drug’s beneficial and adverse effects,...
13-Sep-2017 7:30 AM EDT Add to Favorites

Icahn School of Medicine at Mount Sinai and Unyts Collaborate to Increase Brain Tissue Donation for Autism Research

Coordination Will Aid Research Efforts for a Better Understanding of Autism Spectrum Disorders
12-Sep-2017 3:55 PM EDT Add to Favorites

Mount Sinai and ProHEALTH Dental Announce Innovative Clinical and Academic Affiliation

Poor oral health is an important indicator of overall health and has been linked to serious conditions like heart disease and diabetes.
8-Sep-2017 4:15 PM EDT Add to Favorites

Cocaine Users’ Brains Unable to Extinguish Drug Associations

Mount Sinai researchers study if longtime cocaine users could benefit from a psychological technique that might help them quit
11-Sep-2017 11:15 AM EDT Add to Favorites

Scientists Construct First Predictive Model of Inflammatory Bowel Disease

Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions today published results of an in-depth, multi-omics approach to characterizing the immune component of inflammatory bowel disease (IBD).
11-Sep-2017 11:00 AM EDT Add to Favorites